Feedback / Questions
Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma
https://www.businesswire.com/news/home/20240806271893/en/Equillium-Announces-Positive-Interim-Analysis-from-Phase-3-EQUATOR-Study-of-Itolizumab-in-Acute-Graft-Versus-Host-Disease
Aug 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next